The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II feasibility trial of neoadjuvant chemoradiotherapy combined with atezolizumab for resectable esophageal adenocarcinoma: The PERFECT trial.
 
Tom van den Ende
No Relationships to Disclose
 
Nicolien C. de Clercq
No Relationships to Disclose
 
Mark I. van Berge Henegouwen
Consulting or Advisory Role - Medtronic (Inst)
Research Funding - Olympus (Inst)
Travel, Accommodations, Expenses - Johnson & Johnson
 
Suzanne S. Gisbertz
Consulting or Advisory Role - Medtronic (Inst)
Research Funding - Olympus (Inst)
 
Sybren L. Meijer
No Relationships to Disclose
 
Sandor Schokker
Travel, Accommodations, Expenses - Roche
 
Jacques J.G.H.M. Bergman
Speakers' Bureau - Fujifilm
Research Funding - Fujifilm (Inst); NinePoint Medical (Inst)
 
Nadia Haj Mohammad
Consulting or Advisory Role - CDDI; Celgene; Lilly
 
Jelle P. Ruurda
Other Relationship - Intuitive Surgical
 
Richard van Hillegersberg
No Relationships to Disclose
 
Stella Mook
No Relationships to Disclose
 
Max Nieuwdorp
No Relationships to Disclose
 
Tanya T.D. Soeratram
No Relationships to Disclose
 
Bauke Ylstra
Travel, Accommodations, Expenses - Lilly
 
Nicole C.T. van Grieken
Consulting or Advisory Role - Bristol-Myers Squibb (Inst)
 
Tanja D. de Gruijl
No Relationships to Disclose
 
Maarten F. Bijlsma
No Relationships to Disclose
 
Maarten C.C.M. Hulshof
No Relationships to Disclose
 
Hanneke W.M. Van Laarhoven
Honoraria - Lilly/ImClone
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly/ImClone; Nordic Group
Research Funding - Bayer Schering Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen-Cilag (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Nordic Group (Inst); Philips Healthcare (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca